These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2168549)

  • 1. Analytical determination of receptor-ligand dissociation constants of two populations of receptors from displacement curves.
    Almagor H; Levitzki A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6482-6. PubMed ID: 2168549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity binding of reovirus type 3 to cells that lack beta adrenergic receptor activity.
    Sawutz DG; Bassel-Duby R; Homcy CJ
    Life Sci; 1987 Jan; 40(4):399-406. PubMed ID: 3027484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
    Findell PR; Wong KH; Jackman JK; Daniels DV
    Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Bromoacetyl-amino-cyanopindolol: a highly potent beta-adrenergic affinity label blocks irreversibly a non-protein component tightly associated with the receptor.
    Chorev M; Feigenbaum A; Keenan AK; Gilon C; Levitzki A
    Eur J Biochem; 1985 Jan; 146(1):9-14. PubMed ID: 2981685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An accurate method for determination of receptor-ligand and enzyme-inhibitor dissociation constants from displacement curves.
    Horovitz A; Levitzki A
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6654-8. PubMed ID: 3477796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F; Miyamoto K; Koshiura R
    Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
    Neve KA; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1986 Jul; 238(1):46-53. PubMed ID: 3014123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cells.
    Port JD; Debellis CC; Klein J; Peeters GA; Barry WH; Bristow MR
    J Pharmacol Exp Ther; 1992 Jul; 262(1):217-24. PubMed ID: 1352549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 2-hydroxyestradiol on the number of granulosa cell beta-adrenergic receptors.
    Spicer LJ; Hammond JM
    Endocrinology; 1988 Jun; 122(6):2710-7. PubMed ID: 2836172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization and redistribution of beta-adrenergic receptors on human mononuclear leukocytes.
    Motulsky HJ; Cunningham EM; DeBlasi A; Insel PA
    Am J Physiol; 1986 May; 250(5 Pt 1):E583-90. PubMed ID: 3010734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
    Neve KA; Molinoff PB
    Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of beta-adrenergic receptors in A431 cells in situ. Effect of chronic exposure to agonist.
    Wang HY; Berrios M; Malbon CC
    Biochem J; 1989 Oct; 263(2):533-8. PubMed ID: 2556997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
    Offord SJ; Ordway GA; Frazer A
    J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
    Mahan LC; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):7-15. PubMed ID: 2868411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor metabolism in wild-type, Gs, and protein kinase A-variant S49 cells.
    Jasper JR; Motulsky HJ; Mahan LC; Insel PA
    Am J Physiol; 1990 Jul; 259(1 Pt 1):C41-6. PubMed ID: 1973600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
    Snavely MD; Ziegler MG; Insel PA
    Mol Pharmacol; 1985 Jan; 27(1):19-26. PubMed ID: 2981399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-adrenergic receptor survives solubilization in deoxycholate while forming a stable association with the agonist.
    Nedivi E; Schramm M
    J Biol Chem; 1984 May; 259(9):5803-8. PubMed ID: 6325449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    Marsh JD; Smith TW
    Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.